UBS Group’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.2M | Buy |
107,000
+35,700
| +50% | +$7.52M | ﹤0.01% | 2572 |
|
|
2025
Q4 | $14.2M | Hold |
71,300
| – | – | ﹤0.01% | 2933 |
|
|
2025
Q3 | $14.5M | Buy |
71,300
+17,900
| +34% | +$3.18M | ﹤0.01% | 2916 |
|
|
2025
Q2 | $9.4M | Buy |
53,400
+33,300
| +166% | +$5.01M | ﹤0.01% | 3144 |
|
|
2025
Q1 | $2.7M | Sell |
20,100
-122,500
| -86% | -$16.1M | ﹤0.01% | 4423 |
|
|
2024
Q4 | $18M | Buy |
142,600
+10,100
| +8% | +$1.5M | ﹤0.01% | 2443 |
|
|
2024
Q3 | $22M | Sell |
132,500
-344,300
| -72% | -$52.1M | ﹤0.01% | 1745 |
|
|
2024
Q2 | $63.4M | Buy |
476,800
+349,200
| +274% | +$42M | 0.02% | 886 |
|
|
2024
Q1 | $13.4M | Sell |
127,600
-20,500
| -14% | -$1.84M | ﹤0.01% | 2024 |
|
|
2023
Q4 | $11.2M | Buy |
148,100
+62,900
| +74% | +$3.99M | ﹤0.01% | 2001 |
|
|
2023
Q3 | $5.61M | Buy |
+85,200
| New | +$6.37M | ﹤0.01% | 2461 |
|
|
2023
Q1 | – | Sell |
-34,700
| Closed | -$1.69M | – | 10365 |
|
|
2022
Q4 | $1.69M | Buy |
+34,700
| New | +$1.6M | ﹤0.01% | 3555 |
|
|
2022
Q1 | – | Sell |
-90,000
| Closed | -$7.35M | – | 10893 |
|
|
2021
Q4 | $7.35M | Hold |
90,000
| – | – | ﹤0.01% | 2430 |
|
|
2021
Q3 | $5.98M | Hold |
90,000
| – | – | ﹤0.01% | 2485 |
|
|
2021
Q2 | $6.03M | Hold |
90,000
| – | – | ﹤0.01% | 2493 |
|
|
2021
Q1 | $4.68M | Hold |
90,000
| – | – | ﹤0.01% | 2675 |
|
|
2020
Q4 | $3.59M | Hold |
90,000
| – | – | ﹤0.01% | 2803 |
|
|
2020
Q3 | $2.21M | Sell |
90,000
-5,000
| -5% | -$128K | ﹤0.01% | 2951 |
|
|
2020
Q2 | $1.72M | Buy |
+95,000
| New | +$1.87M | ﹤0.01% | 3014 |
|
|
2018
Q3 | – | Sell |
-45,000
| Closed | -$1.51M | – | 8263 |
|
|
2018
Q2 | $1.51M | Buy |
+45,000
| New | +$1.4M | ﹤0.01% | 3417 |
|
|
2017
Q4 | – | Sell |
-63,000
| Closed | -$1.03M | – | 8095 |
|
|
2017
Q3 | $1.03M | Buy |
+63,000
| New | +$1.07M | ﹤0.01% | 3679 |
|
|
2016
Q1 | – | Sell |
-50,000
| Closed | -$1.51M | – | 8166 |
|
|
2015
Q4 | $1.51M | Hold |
50,000
| – | – | ﹤0.01% | 3063 |
|
|
2015
Q3 | $1.85M | Hold |
50,000
| – | – | ﹤0.01% | 2808 |
|
|
2015
Q2 | $2.89M | Hold |
50,000
| – | – | ﹤0.01% | 2622 |
|
|
2015
Q1 | $2.48M | Sell |
50,000
-600
| -1% | -$28K | ﹤0.01% | 2736 |
|
|
2014
Q4 | $2.56M | Buy |
+50,600
| New | +$2.64M | ﹤0.01% | 2664 |
|
Other funds holding THC
VPM
VCM
LPC
UBS Group's THC Position: Q1 2026 in Review
UBS Group reduced its Tenet Healthcare (THC) stake by 24% in Q1 2026, selling an estimated $22.7M and leaving 336,280 shares worth $63.5M. The position accounts for 0.01% of the portfolio, ranked #1402.
UBS Group first reported a position in THC in Q4 2014 and has held it in 46 quarters since. The position peaked at $99.9M in Q3 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.
- UBS Group held 336,280 shares of Tenet Healthcare worth $63.5M as of Q1 2026.
- UBS Group sold 107,786 Tenet Healthcare shares in Q1 2026, an estimated $22.7M.
- Tenet Healthcare made up 0.01% of UBS Group's portfolio in Q1 2026, its #1402 holding.
- UBS Group first reported a position in Tenet Healthcare in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Tenet Healthcare position peaked at $99.9M in Q3 2025.
- 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.